Cargando…
Design and evaluation of (32)P-labeled hydroxyapatite nanoparticles for bone tumor therapy
The clinical diagnosis and treatment of malignant bone tumors are still major clinical challenges due to their high incidence are difficulty. Targeted therapies have become a critical approach to treat bone tumors. In recent years, radiopharmaceuticals have been used widely and have shown potent and...
Autores principales: | Zhai, Dongliang, Wang, Yumei, Yu, Songke, Zhou, Jiren, Song, Jia, Hao, Shilei, Chen, Xiaoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873276/ https://www.ncbi.nlm.nih.gov/pubmed/36688268 http://dx.doi.org/10.1080/10717544.2023.2168791 |
Ejemplares similares
-
In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded (32)P-nHA Nanoparticles in Prostate Cancer Therapy
por: Deng, Hao, et al.
Publicado: (2023) -
Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect
por: Zhang, Kun, et al.
Publicado: (2019) -
Development of keratin nanoparticles for controlled gastric mucoadhesion and drug release
por: Cheng, Zhongjun, et al.
Publicado: (2018) -
Biomaterial-assisted tumor therapy: A brief review of hydroxyapatite nanoparticles and its composites used in bone tumors therapy
por: Zhang, Quan, et al.
Publicado: (2023) -
Hydroxyapatite nanoparticle-modified porous bone grafts with improved cell attachment
por: Dhavalikar, Prachi, et al.
Publicado: (2023)